In the UK, GLP-1 prescribing remains guided by clinical factors: licensing, availability, existing health conditions, and how the patient responds once treatment starts
Sanjay Gupta 00:01:18 One of my favorite guests
Final Thoughts Early and ongoing research shows promising results for the MOTS-c peptide, especially in metabolic health, but more human studies are needed to confirm its effectiveness
Durable weight loss was maintained 21 days after dosing
Standard concentration: 24% Application amount: 36 drops per area, fingertip application Frequency: Once or twice daily morning and/or evening Timing: After cleansing, before moisturizer Amount by area: Face: 35 drops Neck/dcolletage: 58 drops Scalp (hair growth): 810 drops massaged in, leave on Injectable vs topical which one do you actually need
Purpose-built for physicians GLP-1 receptor agonists may manage idiopathic intracranial hypertension Key takeaways: Patients with idiopathic intracranial hypertension can be managed medically